Recombinant CD47 (Magrolimab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) 抗体 (ABIN7488214)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Magrolimab Biosimilar - Anti-CD47 mAb
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4 kappa
-
-
anti-CD47 (Magrolimab Biosimilar) antibody
Research Grade 适用: 人 ELISA, FACS 宿主: Humanized Mouse Chimeric unconjugated Recombinant Antibody
anti-CD47 (Magrolimab Biosimilar) antibodyResearch Grade 适用: 人 ELISA, FACS 宿主: Human Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD47 (Magrolimab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Hu5F9-G4
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity. -
CAS-编号
- 2169232-81-7
抗原
-
